Now AOAC Approved, CompactDry Total Count Rapid is primed to streamline HACCP Compliance for local producers

Posted 6 Mar 2023

NZMS Scientific today unveils AOAC approval for Compact Dry Total Count Rapid (TCR), validated for 11 matrices including 3 dairy matrices. To celebrate the launch, NZMS Scientific is offering a FREE Total Count Rapid Sample with any Compact Dry purchase. Add both compact dry & sample to your cart to claim the discount. Offer ends 31/5/2023. Click to Claim... Read more

NZMS Diabetes Launches the next-generation Dexcom CGM, Dexcom G7!

Posted 27 Oct 2022

New Zealand first in the southern hemisphere to launch Dexcom G7 Continuous Glucose Monitoring System to improve diabetes management for Kiwis Latest technology becomes available as November marks World Diabetes Day and New Zealand Diabetes Action Month AUCKLAND, New Zealand – Thursday Oct. 27, 2022 – Dexcom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous... Read more

Dexcom unveils update for Dexcom G6 App with New and Improved Features

Posted 15 Oct 2021

Dexcom unveils update for Dexcom G6 App with New and Improved Features We are thrilled to bring you an update to the Dexcom G6 app! Designed to improve the user's experience, this update (v1.9.0) affects all customers who are using Dexcom G6 CGM. The 1.9.0 update allows you, as a Dexcom G6 customer, to access a number of new and improved features, such as: i. An increase in the... Read more

Dexcom, Inc. acquires AMSL and NZMS

Posted 5 Aug 2021

Press Release August 2021 Dexcom, Inc. acquires AMSL and NZMS Richard Plowright, Managing Director and Owner of Australasian Medical & Scientific Limited (AMSL) and New Zealand Medical & Scientific (NZMS) has announced his retirement, after over 30 years of providing the Australasian market with access to leading edge healthcare solutions from all over the world. As of the 1st... Read more

New feeding device agreement

Posted 9 Jul 2021

NZMS has successfully entered into an agreement with Pharmac to supply feeding devices delivered Enterally and Orally. The IOS standard connector - ENFit was originally introduced to the market in 2016. NZMS in partnership with Medicina was at the forefront to bringing ENFit to New Zealand Healthcare. The Medicina ENFit ISO Enteral feeding system range includes a low dose syringe for... Read more

Australian Tandem TGA Suspension Announcement - Issued 25th November 2020.

Posted 25 Nov 2020

Recently the Australian Therapeutic Goods Administration (TGA) expressed concern about the Tandem Diabetes Care t:slim X2 insulin pump. This concern arose after Tandem Diabetes Care submitted user complaints to the TGA as part of its regular product reporting. Tandem Diabetes Care has been in discussions with the TGA to address their concern.  However the TGA has informed Tandem... Read more

Accuvein® in the News

Posted 9 Nov 2020

Taranaki District Health Board’s Child and Adolescent Community Centre are excited with the introduction of their first AccuVein® monitor. Full article here. Read more

Basal-IQ Technology update available in New Zealand for t:slim X2™ Insulin Pump from Tandem Diabetes Care®

Posted 27 Aug 2020

NZMS Diabetes is excited to announce the Basal-IQTM Technology update for the Tandem t:slim X2TM insulin pump. Basal-IQ Technology predicts and helps prevent lows with ZERO fingerpricks* using Dexcom G6 System. Check here for more information * If your glucose alerts and readings do not match your symptoms or expectations perform a fingerprick to confirm your blood... Read more

Dexcom G6 CGM available in New Zealand

Posted 11 May 2020

Revolutionary new CGM system eliminates routine fingerpricks* for people with diabetes and is nearly one-third slimmer than previous generation. NZMS Diabetes is excited to announce the powerful and revolutionary Dexcom G6 Continuous Glucose Monitoring System (CGM) is available in New Zealand for people with diabetes ages 2 years and up. New with Dexcom G6: Fingerprick... Read more

Revolutionary t:slim X2™ Insulin Pump from Tandem Diabetes Care® coming to New Zealand patients

Posted 24 Apr 2018

NZMS Diabetes announce a new partnership with Tandem Diabetes Care to introduce the t:slim X2™ Insulin Pump to New Zealand. NZMS Diabetes are delighted to announce they have partnered with Tandem Diabetes Care®, Inc. to introduce the full colour touchscreen t:slim X2™ Insulin Pump to the New Zealand market for the very first time. This partnership is set to benefit New Zealand... Read more

NZMS signs exclusive distribution agreement with Valeritas

NZMS signs exclusive distribution agreement with Valeritas

Posted 18 Apr 2018

NZMS are pleased to announce they have signed an exclusive distribution agreement with Valeritas Holdings, Inc. to market their V-Go® Wearable Insulin Delivery device, for patients with type 2 diabetes, in New Zealand.  “Adding V-Go® to our portfolio is a significant step towards addressing the needs of New Zealand patients with type 2 diabetes who want simple and effective... Read more

Dexcom G5 Mobile wins Healthcare Innovation Award

Posted 27 Jun 2017

New Zealand Medical & Scientific (NZMS) was presented the award for the Dexcom G5 Mobile™ by Jonathan Lucas, partner at James & Wells, at Health Tech Week Gala Dinner. NZMS is the New Zealand distributor for Dexcom Corporation, the United States company that created the device. More than 240,000 New Zealanders have type 1 or 2 diabetes. Dexcom G5™ helps diabetics to... Read more

Results of the PATHWAY study of AspireAssist® have been published.

Posted 8 Dec 2016

Results of the PATHWAY study of AspireAssist®, a 171-subject, multicentre randomized control trial in the US, have been published yesterday in the American Journal of Gastroenterology, which mark a significant milestone for the AspireAssist paving the way for worldwide acceptance and adoption. The published results show that patients lost an average of 37% of their excess weight... Read more

Updated ASTRO guideline

Posted 29 Nov 2016

Updated ASTRO guideline expands pool of suitable candidates for accelerated partial breast irradiation. BioZorb Tissue Marker assists with radiation targeting, including APBI targeting, more information on BioZorb here. Read more

Dexcom G5 Mobile now in New Zealand

Posted 17 Mar 2016

NZMS Diabetes is excited to announce the launch of Dexcom G5 Mobile in New Zealand. Dexcom G5 Mobile is the latest generation CGM featuring mobile connectivity, the ability to remotely share data with up to five followers and superior accuracy giving users freedom from confirmatory fingerprick testing. Read how Dexcom G5 Mobile has helped the Hall family in the NZ Herald article here.... Read more

New Medicina ENFit ISO Enteral feeding system range

New Medicina ENFit ISO Enteral feeding system range

Posted 8 Nov 2015

NZMS and Medicina are pleased to announce, that in line with the joint effort worldwide, the new ISO Standard 80369-3 Reducing the risk of medical device tubing misconnections for enteral feeding will be available for our New Zealand Customers. The new Medicina ENFit ISO Enteral feeding system range includes a low dose syringe for the smallest of patients and has been developed to deliver... Read more